Ergoteles’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Ergoteles’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-88,900	Closed	-$26.5K	–	989
2023 Q2	$26.5K	Buy	+88,900	New	+$26.8K	﹤0.01%	977

Ergoteles's GRNA Position: Q3 2023 in Review

Ergoteles sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 88,900 shares — an estimated $26.5K sold.

Ergoteles first reported a position in GRNA in Q2 2023 and held it in 1 quarter. The position peaked at $26.5K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Ergoteles reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 88,900 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $26.5K.
Ergoteles first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2023 and held it in 1 quarter.
Ergoteles's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $26.5K in Q2 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.